Lucid Diagnostics Stock (NASDAQ: LUCD) stock price, news, charts, stock research, profile.
You can purchase shares of Lucid Diagnostics (NASDAQ:LUCD) through any online brokerage.
Other companies in Lucid Diagnostics’s space includes: LENSAR (NASDAQ:LNSR), Nexalin Technology (NASDAQ:NXL), Baird Medical Investment (NASDAQ:BDMD), Modular Medical (NASDAQ:MODD) and Envoy Medical (NASDAQ:COCH).
Lucid Diagnostics has a consensus price target of $3.71.
The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $0.9784 last updated November 22, 2024 at 6:11 PM EST.
There are no upcoming dividends for Lucid Diagnostics.
Lucid Diagnostics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Lucid Diagnostics.
Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.